Related Experiment Videos
New developments in the treatment of hypoplastic left heart syndrome
1Columbus Children's Hospital, Division of Cardiothoracic Surgery, OH 43205-2696, USA.
Insights
Significant advancements in treating hypoplastic left heart syndrome (HLHS) have improved survival rates. Staged surgical palliation now offers a 58% survival rate at 5 years, a major improvement for congenital heart disease.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Surgical Innovation
Background:
- Hypoplastic left heart syndrome (HLHS) historically had over 95% mortality by 1 month of age.
- Early surgical interventions dramatically improved outcomes for this severe congenital heart defect.
Purpose of the Study:
- To review the progress and current status of treatment for HLHS.
- To highlight advancements in surgical palliation and cardiac transplantation for HLHS.
- To discuss ongoing research in risk factor identification and in utero monitoring.
Main Methods:
- Review of historical and current survival data for HLHS.
- Analysis of outcomes associated with staged surgical palliation.
- Evaluation of short-term results for cardiac transplantation in HLHS patients.
- Discussion of advancements in surgical techniques and postoperative care, including the Norwood operation.
- Mention of fetal ultrasonography for in utero monitoring.
Main Results:
- Actuarial survival for staged surgical palliation has reached 58% at 5 years of age.
- Short-term outcomes for cardiac transplantation in HLHS appear excellent.
- Refinements in surgical techniques and postoperative care have reduced risks associated with the Norwood operation and intensive care unit management.
Conclusions:
- Modern treatment strategies have significantly improved survival for children with HLHS.
- While outcomes are improving, practice patterns and opinions on universal surgical treatment vary.
- Comfort care remains a viable option for families facing HLHS diagnoses.
Abstract:
Progress has been made in the treatment of children born with hypoplastic left heart syndrome. From a mortality of more than 95% at 1 month of age in an era prior to surgical intervention, an actuarial survival of 58% at 5 years of age for staged surgical palliation is now being achieved. The short-term results with cardiac transplantation also appear to be excellent. Efforts are being directed at identifying potential risk factors, and fetal ultrasonography is capable of monitoring the progression of this malformation in utero. Refinements in surgical technique and postoperative care have been achieved, reducing the overall risk of the Norwood operation and sudden hemodynamic instability in the intensive care unit. Practice patterns and perceptions of outcome vary widely. Presently there is no unanimity of opinion that surgical therapy should be offered to all patients, and comfort care continues to be a family option.